New York Medical College

Contact

Augustine Moscatello, M.D., M.S., completed his post-doctoral training as chief resident in otolaryngology at The Mount Sinai Medical Center in New York City. He is board-certified in otolaryngology/head and neck surgery and has consistently been listed as one of America's, New York's and Westchester's Top Doctors since 1994.

Dr. Moscatello serves as director of the Department of Otolaryngology/Head and Neck Surgery at the Westchester Medical Center. He has given numerous presentations and lectures and has published articles in his areas of expertise.

Clinical Specialty

Head and Neck Surgery, including major and minor head and neck cancer surgery
Balloon Sinus Surgery
Minimally Invasive Thyroid Surgery
Pillar Procedures for Sleep Apnea and Snoring

Education

Residency, Otolaryngology, Mount Sinai Medical Center
Internship, Surgery, Mount Sinai Medical Center
M.D., Mount Sinai School of Medicine

Honors and Awards

Member, Alpha Omega Alpha Medical Honor Society

Publications

Carnazza M, Quaranto D, DeSouza N, et. al. "The Current Understanding of the Molecular Pathogenesis of Papillary Thyroid Cancer." International journal of molecular sciences, 26(10), (2025) . doi: 10.3390/ijms26104646
Maskey AR, Carnazza M, Spears M, et. al. "Berberine Suppression of Human IgE but Not IgG Production via Inhibition of STAT6 Binding Activity at IgE Promoter by BCL6." Cells, 14(8), (2025) . doi: 10.3390/cells14080591
Abraham MT, Rousso JJ, Hu S, et. al. "Introduction of the American Academy of Facial Plastic and Reconstructive Surgery FACE TO FACE Database." The Journal of craniofacial surgery, 28(5), (2017) 1171-1174. doi: 10.1097/SCS.0000000000003590
Abraham MT, Rousso JJ, Hu S, et. al. "Creation of the American Academy of Facial Plastic and Reconstructive Surgery FACE TO FACE Database." JAMA facial plastic surgery, 19(2), (2017) 158-160. doi: 10.1001/jamafacial.2016.1286
Hanly EK, Tuli NY, Bednarczyk RB, et. al. "Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells." Oncotarget, 7(8), (2016) 8676-87. doi: 10.18632/oncotarget.6779
Hanly EK, Bednarczyk RB, Tuli NY, et. al. "mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib." Oncotarget, 6(37), (2015) 39702-13. doi: 10.18632/oncotarget.4052
Ormond DR, Moscatello AL, Murali R, et. al. "MRI findings of causalgia of the lower extremity following transsphenoidal resection of pituitary tumor." Case reports in neurological medicine, 2012(), (2012) 598048.

View All Publications

Memberships and Affiliations